2456 Nucleic Acids Research, 2008, Vol. 36, No. 7 reference standard for human cell lines. Proc. Natl Acad. Sci. USA., 98, 8012–8017. 6. Thompson,E.W., Waltham,M., Ramus,S.J., Hutchins,A.M., Armes,J.E., Campbell,I.G., Williams,E.D., Thompson,P.R., Rae,J.M., Johnson,M.D. et al. (2004) LCC15-MB cells are MDA-MB-435: a review of misidentiﬁed breast and prostate cell lines. Clin. Exp. Metastasis, 21, 535–541. 7. Chatterjee,R. (2007) Cell biology. Cases of mistaken identity. Science, 315, 928–931. 8. Parson,W., Kirchebner,R., Muhlmann,R., Renner,K., Koﬂer,A., Schmidt,S. and Koﬂer,R. (2005) Cancer cell line identiﬁcation by short tandem repeat proﬁling: power and limitations. FASEB J, 19, 434–436. 9. Rosenberg,N.A., Li,L.M., Ward,R. and Pritchard,J.K. (2003) Informativeness of genetic markers for inference of ancestry. Am. J. Hum. Genet., 73, 1402–1422. 10. Heaton,M.P., Harhay,G.P., Bennett,G.L., Stone,R.T., Grosse,W.M., Casas,E., Keele,J.W., Smith,T.P., Chitko- McKown,C.G., Laegreid,W.W. et al. (2002) Selection and use of SNP markers for animal identiﬁcation and paternity analysis in U.S. beef cattle. Mamm. Genome, 13, 272–281. 11. Lao,O., van Duijn,K., Kersbergen,P., de Knijﬀ,P. and Kayser,M. (2006) Proportioning whole-genome single-nucleotide-polymorph- ism diversity for the identiﬁcation of geographic population structure and genetic ancestry. Am. J. Hum. Genet., 78, 680–690. 12. Kidd,K.K., Pakstis,A.J., Speed,W.C., Grigorenko,E.L., Kajuna,S.L., Karoma,N.J., Kungulilo,S., Kim,J.J., Lu,R.B., Odunsi,A. et al. (2006) Developing a SNP panel for forensic identiﬁcation of individuals. Forensic Sci. Int., 164, 20–32. 13. Perner,S., Demichelis,F., Beroukhim,R., Schmidt,F.H., Mosquera,J.M., Setlur,S., Tchinda,J., Tomlins,S.A., Hofer,M.D., Pienta,K.G. et al. (2006) TMPRSS2:ERG fusion associated dele- tions provide insight into the heterogeneity of prostate cancer. Cancer Res., 66, 8337–8341. 14. Zhao,J.J., Gjoerup,O.V., Subramanian,R.R., Cheng,Y., Chen,W., Roberts,T.M. and Hahn,W.C. (2003) Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell, 3, 483–495. 15. Zhao,X., Weir,B.A., LaFramboise,T., Lin,M., Beroukhim,R., Garraway,L., Beheshti,J., Lee,J.C., Naoki,K., Richards,W.G. et al. (2005) Homozygous deletions and chromosome ampliﬁcations in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res, 65, 5561–5570. 16. Monks,A., Scudiero,D.A., Johnson,G.S., Paull,K.D. and Sausville,E.A. (1997) The NCI anti-cancer drug screen: a smart screen to identify eﬀectors of novel targets. Anticancer Drug Des., 12, 533–541. 17. Ross,D.T., Scherf,U., Eisen,M.B., Perou,C.M., Rees,C., Spellman,P., Iyer,V., Jeﬀrey,S.S., Van de Rijn,M., Waltham,M. et al. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet., 24, 227–235. 18. Scherf,U., Ross,D.T., Waltham,M., Smith,L.H., Lee,J.K., Tanabe,L., Kohn,K.W., Reinhold,W.C., Myers,T.G., Andrews,D.T. et al. (2000) A gene expression database for the molecular pharmacology of cancer. Nat. Genet., 24, 236–244. 19. Bright,R.K., Vocke,C.D., Emmert-Buck,M.R., Duray,P.H., Solomon,D., Fetsch,P., Rhim,J.S., Linehan,W.M. and Topalian,S.L. (1997) Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res., 57, 995–1002. 20. Macoska,J.A., Paris,P., Collins,C., Andaya,A., Beheshti,B., Chaib,H., Kant,R., Begley,L., MacDonald,J.W., Squire,J.A. et al. (2004) Evolution of 8p loss in transformed human prostate epithelial cells. Cancer Genet. Cytogenet., 154, 36–43. 21. Begley,L., Keeney,D., Beheshti,B., Squire,J.A., Kant,R., Chaib,H., MacDonald,J.W., Rhim,J. and Macoska,J.A. (2006) Concordant copy number and transcriptional activity of genes mapping to derivative chromosomes 8 during cellular immortalization in vitro. Genes Chromosomes Cancer, 45, 136–146. 22. Tang,K., Fu,D.J., Julien,D., Braun,A., Cantor,C.R. and Koster,H. (1999) Chip-based genotyping by mass spectrometry. Proc. Natl Acad. Sci. USA, 96, 10016–10020. 23. Team,R.D.C. (2006) R: A Language and Environment for Statistical Computing, Vienna, Austria. 24. Hurnanen,D., Chan,H.M. and Kubow,S. (1997) The protective eﬀect of metallothionein against lipid peroxidation caused by retinoic acid in human breast cancer cells. J. Pharmacol. Exp. Ther., 283, 1520–1528. 25. Elstner,E., Linker-Israeli,M., Said,J., Umiel,T., de Vos,S., Shintaku,I.P., Heber,D., Binderup,L., Uskokovic,M. and Koeﬄer,H.P. (1995) 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of diﬀerentiation of human breast cancer cell lines. Cancer Res., 55, 2822–2830. 26. Macoska,J.A., Beheshti,B., Rhim,J.S., Hukku,B., Lehr,J., Pienta,K.J. and Squire,J.A. (2000) Genetic characterization of immortalized human prostate epithelial cell cultures. Evidence for structural rearrangements of chromosome 8 and i(8q) chromosome formation in primary tumor-derived cells. Cancer Genet. Cytogenet., 120, 50–57. 27. Steenbergen,R.D., Hermsen,M.A., Walboomers,J.M., Joenje,H., Arwert,F., Meijer,C.J. and Snijders,P.J. (1995) Integrated human papillomavirus type 16 and loss of Heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res., 55, 5465–5471. 28. van Bokhoven,A., Varella-Garcia,M., Korch,C., Hessels,D. and Miller,G.J. (2001) Widely used prostate carcinoma cell lines share common origins. Prostate, 47, 36–51. 29. Consortium,I.H. (2005) A haplotype map of the human genome. Nature, 437, 1299–1320. 30. Lin,Z., Owen,A.B. and Altman,R.B. (2004) Genetics. Genomic research and human subject privacy. Science, 305, 183. 31. Gaustadnes,M., Orntoft,T.F., Jensen,J.L. and Torring,N. (2006) Validation of the use of DNA pools and primer extension in association studies of sporadic colorectal cancer for selection of candidate SNPs. Hum. Mutat., 27, 187–194.